7,3′,4′-Trihydroxyisoflavone, a Metabolite of the Soy Isoflavone Daidzein, Suppresses α-Melanocyte-Stimulating Hormone-Induced Melanogenesis by Targeting Melanocortin 1 Receptor
7,3′,4′-Trihydroxyisoflavone (7,3′,4′-THIF) is a metabolite of daidzein which is a representative isoflavone found in soybean. Recent studies suggested that 7,3′,4′-THIF exerts a hypopigmentary effect in B16F10 cells, however, its underlying molecular mechanisms and specific target protein remain unknown. Here, we found that 7,3′,4′-THIF, but not daidzein, inhibited α-melanocyte-stimulating hormone (MSH)-induced intracellular and extracellular melanin production in B16F10 cells by directly targeting melanocortin 1 receptor (MC1R). Western blot data showed that 7,3′,4′-THIF inhibited α-MSH-induced tyrosinase, tyrosinase-related protein-1 (TYRP-1), and tyrosinase-related protein-2 (TYRP-2) expressions through the inhibition of Microphthalmia-associated transcription factor (MITF) expression and cAMP response element-binding (CREB) phosphorylation. 7,3′,4′-THIF also inhibited α-MSH-induced dephosphorylation of AKT and phosphorylation of p38 and cAMP-dependent protein kinase (PKA). cAMP and Pull-down assays indicated that 7,3′,4′-THIF strongly inhibited forskolin-induced intracellular cAMP production and bound MC1R directly by competing with α-MSH. Moreover, 7,3′,4′-THIF inhibited α-MSH-induced intracellular melanin production in human epidermal melanocytes (HEMs). Collectively, these results demonstrate that 7,3′,4′-THIF targets MC1R, resulting in the suppression of melanin production, suggesting a protective role for 7,3′,4′-THIF against melanogenesis.
Top-30
Journals
|
1
2
|
|
|
Plants
2 publications, 11.11%
|
|
|
Molecules
2 publications, 11.11%
|
|
|
International Journal of Molecular Sciences
2 publications, 11.11%
|
|
|
Molecular Medicine Reports
1 publication, 5.56%
|
|
|
Microorganisms
1 publication, 5.56%
|
|
|
Scientific Reports
1 publication, 5.56%
|
|
|
Biochemical Pharmacology
1 publication, 5.56%
|
|
|
European Journal of Pharmacology
1 publication, 5.56%
|
|
|
BioFactors
1 publication, 5.56%
|
|
|
Bioorganic and Medicinal Chemistry
1 publication, 5.56%
|
|
|
Frontiers in Plant Science
1 publication, 5.56%
|
|
|
International Journal of Molecular Medicine
1 publication, 5.56%
|
|
|
Journal of Traditional Chinese Medical Sciences
1 publication, 5.56%
|
|
|
Medicine (United States)
1 publication, 5.56%
|
|
|
Journal of Ethnopharmacology
1 publication, 5.56%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
|
|
|
MDPI
7 publications, 38.89%
|
|
|
Elsevier
5 publications, 27.78%
|
|
|
Spandidos Publications
2 publications, 11.11%
|
|
|
Springer Nature
1 publication, 5.56%
|
|
|
Wiley
1 publication, 5.56%
|
|
|
Frontiers Media S.A.
1 publication, 5.56%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 5.56%
|
|
|
1
2
3
4
5
6
7
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.